Cargando…
Bioimaging of Nucleolin Aptamer-Containing 5-(N-benzylcarboxyamide)-2′-deoxyuridine More Capable of Specific Binding to Targets in Cancer Cells
Chemically modified nucleotides have been developed and applied into SELEX procedure to find a novel type of aptamers to fit with targets of interest. In this study, we directly performed chemical modification of 5-(N-benzylcarboxyamide)-2′-deoxyuridine (called 5-BzdU) in the AS1411 aptamer, which b...
Autores principales: | Lee, Kyue Yim, Kang, Hyungu, Ryu, Sung Ho, Lee, Dong Soo, Lee, Jung Hwan, Kim, Soonhag |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829770/ https://www.ncbi.nlm.nih.gov/pubmed/20204158 http://dx.doi.org/10.1155/2010/168306 |
Ejemplares similares
-
Insights into the binding mode of AS1411 aptamer to nucleolin
por: Bie, Lihua, et al.
Publicado: (2022) -
AS1411 Nucleolin-Specific Binding Aptamers Reduce Pathological Angiogenesis through Inhibition of Nucleolin Phosphorylation
por: Iturriaga-Goyon, Emilio, et al.
Publicado: (2021) -
Anti-nucleolin aptamer AS1411: an advancing therapeutic
por: Van den Avont, Alexander, et al.
Publicado: (2023) -
Grafting of anti-nucleolin aptamer into preformed and remotely loaded liposomes through aptamer-cholesterol post-insertion
por: Nsairat, Hamdi, et al.
Publicado: (2020) -
Nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry–based imaging
por: Subramanian, Nithya, et al.
Publicado: (2016)